1. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study
2. Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
3. Impact of azacitidine before allogeneic stem‐cell transplantation for myelodysplastic syndromes: a study by the Societe Francaise de Greffe de Moelle et de Therapie‐Cellulaire and the Groupe‐Francophone des Myelodysplasies;Damaj G.;J Clin Oncol,2012
4. Up‐front allogeneic stem cell transplantation following reduced intensity/nonmyeloablative for patients with myelodysplastic syndrome. a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC);Damaj G.;Biol Blood Marrow Transplant,2014
5. CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes